News

Despite global alerts, development of mpox therapeutics and diagnostics has failed to match the urgency of recent outbreaks.

Racial disparities continue to affect kidney transplant outcomes in patients with SLE, even after the 2014 revision of the Kidney Allocation System designed to improve organ distribution equity.

Tiny brain-like organoids, sometimes called “mini brains”, are at the center of a bold new approach to computing that merges biology with technology.

Methotrexate use does not appear to increase the risk or accelerate the progression of interstitial lung disease in patients with rheumatoid arthritis.

Oral JAK inhibitors are associated with measurable increases in lipid levels, emphasizing the need for vigilant cardiovascular monitoring during treatment.

At ACR 2025, early data of CTA313, a universal CD19/BCMA CAR-T therapy, demonstrate safety and strong responses in refractory lupus, offering hope for durable remission.

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid arthritis flares and inflammation.

Persistent depression during adjuvant cancer therapy heightens treatment toxicity and significantly worsens overall QoL in early-stage cancer.